CVS CVS Health Corp

$70.16

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/18/2025

About CVS Health Corp

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Website: https://www.cvshealth.com

Sector
TRADE & SERVICES
Industry
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
64803
Address
ONE CVS DR., WOONSOCKET, RI, US
Valuation
Market Cap
$84.95B
P/E Ratio
18.39
PEG Ratio
0.70
Price to Book
1.12
Performance
EPS
$3.66
Dividend Yield
3.95%
Profit Margin
1.25%
ROE
6.02%
Technicals
50D MA
$65.40
200D MA
$58.69
52W High
$71.45
52W Low
$43.01
Fundamentals
Shares Outstanding
1B
Target Price
$75.97
Beta
0.57

CVS EPS Estimates vs Actual

Estimated
Actual

CVS News & Sentiment

Aug 18, 2025 • Benzinga SOMEWHAT-BULLISH
Why Is UnitedHealth Group Stock Gaining Monday? - UnitedHealth Group ( NYSE:UNH )
BofA forecasts UnitedHealth earnings rebound by 2027, raising target to $325. The 2027 Medicare Advantage update and Star Ratings will shape profitability. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more.
Aug 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead?
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Aug 18, 2025 • Zacks Commentary NEUTRAL
Lilly Stock Down 5% This Month: Should You Buy the Dip?
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill orforglipron disappointed.
Aug 18, 2025 • Benzinga SOMEWHAT-BULLISH
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - CVS Health ( NYSE:CVS ) , Cogent Comms Hldgs ( NASDAQ:CCOI )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Justin Patterson upgraded Duolingo, Inc.
Aug 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Investors Heavily Search CVS Health Corporation ( CVS ) : Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Aug 16, 2025 • Benzinga NEUTRAL
Costco Refuses To Stock Abortion Pill Mifepristone, Pointing To 'Low Demand' As Activist Groups Step Up Pressure On Retail Giants - Costco Wholesale ( NASDAQ:COST ) , Albertsons Companies ( NYSE:ACI )
Costco Wholesale Corp. COST announced on Thursday it will not sell abortion pill mifepristone across its U.S. pharmacy locations, citing insufficient member demand amid mounting pressure from religious activist groups targeting major retailers. Check out the current price of COST stock here.
Sentiment Snapshot

Average Sentiment Score:

0.351
50 articles with scored sentiment

Overall Sentiment:

Bullish

CVS Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Pre market)
0.58 Surprise
  • Reported EPS: $2.25
  • Estimate: $1.67
  • Whisper:
  • Surprise %: 34.5%
Feb 05, 2025
Dec 31, 2024 (Pre market)
0.27 Surprise
  • Reported EPS: $1.19
  • Estimate: $0.92
  • Whisper:
  • Surprise %: 29.6%
Nov 06, 2024
Sep 30, 2024 (Pre market)
-0.44 Surprise
  • Reported EPS: $1.09
  • Estimate: $1.53
  • Whisper:
  • Surprise %: -28.8%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.1 Surprise
  • Reported EPS: $1.83
  • Estimate: $1.73
  • Whisper:
  • Surprise %: 5.8%
May 01, 2024
Mar 31, 2024 (Pre market)
-0.39 Surprise
  • Reported EPS: $1.31
  • Estimate: $1.70
  • Whisper:
  • Surprise %: -22.9%
Feb 07, 2024
Dec 31, 2023 (Pre market)
0.13 Surprise
  • Reported EPS: $2.12
  • Estimate: $1.99
  • Whisper:
  • Surprise %: 6.5%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.08 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.13
  • Whisper:
  • Surprise %: 3.8%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.11
  • Whisper:
  • Surprise %: 4.7%
May 03, 2023
Mar 31, 2023 (Pre market)
0.11 Surprise
  • Reported EPS: $2.20
  • Estimate: $2.09
  • Whisper:
  • Surprise %: 5.3%

Financials